Follow on Study From RE-ALIGN

Status:
Terminated

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

To collect additional data relating to safety and indicators of efficacy for patients who have participated in the 1160.113 study.

Phase 2

Boehringer Ingelheim

Dabigatran
Warfarin